May 2, 2007 -- MRI contrast developer Epix Pharmaceuticals of Lexington, MA, said its chairman, Christopher Gabrieli, is retiring.

Gabrieli was an early investor in Epix and has provided the company with invaluable counsel over the years, according to the firm. His position as chairman on the board will be filled by Frederick Frank, currently an Epix board member.

By AuntMinnie.com staff writers
May 2, 2007

Epix regains Nasdaq compliance, April 13, 2007

Epix Pharma says decision on contrast agent may take longer, April 3, 2007

Epix files formal appeal for Vasovist, February 28, 2007

Epix to restate past financial reports, February 26, 2007

Epix files U.S. Vasovist appeal, December 15, 2006

Copyright © 2007 AuntMinnie.com

 

To read this and get access to all of the exclusive content on AuntMinnie.com create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a AuntMinnie.com password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking
account: